Notably, analyzing the TCGA-LIHC dataset suggested that levels of EP300 were inversely correlated with those of SNRPD2 in human HCC samples, and high EP300 levels did not correlate with poor survival in HCC patients (Supplementary Fig. 5i, j). Here, SNRPD2 is linked to hepatocellular carcinoma.